Peter Riegman

5.6k total citations · 1 hit paper
70 papers, 3.8k citations indexed

About

Peter Riegman is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Peter Riegman has authored 70 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 14 papers in Genetics and 14 papers in Cancer Research. Recurrent topics in Peter Riegman's work include Molecular Biology Techniques and Applications (19 papers), Cancer Genomics and Diagnostics (11 papers) and Ethics in Clinical Research (11 papers). Peter Riegman is often cited by papers focused on Molecular Biology Techniques and Applications (19 papers), Cancer Genomics and Diagnostics (11 papers) and Ethics in Clinical Research (11 papers). Peter Riegman collaborates with scholars based in Netherlands, Italy and Austria. Peter Riegman's co-authors include Jan Trapman, R.J. Vlietstra, J.A.G.M. van der Korput, Albert O. Brinkmann, Manuel M. Morente, J.C. Romijn, Jun Hou, Bianca den Hamer, Henk C. Hoogsteden and Sjaak Philipsen and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Peter Riegman

68 papers receiving 3.7k citations

Hit Papers

Gene Expression-Based Cla... 2010 2026 2015 2020 2010 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Peter Riegman 1.9k 924 766 513 505 70 3.8k
Jianrong Wu 1.5k 0.8× 1.6k 1.8× 571 0.7× 1.4k 2.7× 229 0.5× 158 4.5k
Anil Potti 2.7k 1.4× 1.2k 1.3× 1.4k 1.9× 2.1k 4.2× 504 1.0× 103 5.3k
Gary A. Ulaner 1.4k 0.8× 930 1.0× 849 1.1× 1.6k 3.1× 559 1.1× 186 5.1k
Qianxing Mo 3.2k 1.7× 933 1.0× 1.0k 1.3× 1.8k 3.5× 545 1.1× 138 6.2k
Bjørn Risberg 1.8k 0.9× 761 0.8× 877 1.1× 1.4k 2.7× 263 0.5× 131 4.6k
Jane E. Armes 1.7k 0.9× 406 0.4× 936 1.2× 1.5k 3.0× 792 1.6× 100 4.6k
Johan Botling 2.8k 1.5× 1.1k 1.2× 1.2k 1.6× 1.6k 3.1× 289 0.6× 117 5.3k
Stephen Francis 834 0.4× 478 0.5× 1.0k 1.3× 1.3k 2.6× 797 1.6× 73 3.3k
Heikki Helin 985 0.5× 879 1.0× 460 0.6× 1.4k 2.6× 343 0.7× 117 3.9k

Countries citing papers authored by Peter Riegman

Since Specialization
Citations

This map shows the geographic impact of Peter Riegman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Riegman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Riegman more than expected).

Fields of papers citing papers by Peter Riegman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Riegman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Riegman. The network helps show where Peter Riegman may publish in the future.

Co-authorship network of co-authors of Peter Riegman

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Riegman. A scholar is included among the top collaborators of Peter Riegman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Riegman. Peter Riegman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bosch, Thierry van den, Lennard J. M. Dekker, Michail Doukas, et al.. (2019). Cryo-Gel embedding compound for renal biopsy biobanking. Scientific Reports. 9(1). 15250–15250. 5 indexed citations
2.
Devereux, Lisa, Peter H. Watson, Anne‐Marie Mes‐Masson, et al.. (2019). A Review of International Biobanks and Networks: Success Factors and Key Benchmarks—A 10-Year Retrospective Review. Biopreservation and Biobanking. 17(6). 512–519. 8 indexed citations
3.
Dagher, Georges, Karl‐Friedrich Becker, Serena Bonin, et al.. (2019). Pre-analytical processes in medical diagnostics: New regulatory requirements and standards. New Biotechnology. 52. 121–125. 30 indexed citations
4.
Lalmahomed, Zarina S., et al.. (2017). Multicenter fresh frozen tissue sampling in colorectal cancer: does the quality meet the standards for state of the art biomarker research?. Cell and Tissue Banking. 18(3). 425–431. 13 indexed citations
5.
Schneider, Daniel J., Peter Riegman, Maureen Cronin, et al.. (2016). Accelerating the Development and Validation of New Value-Based Diagnostics by Leveraging Biobanks. Public Health Genomics. 19(3). 160–169. 5 indexed citations
6.
Kap, Marcel, et al.. (2015). The Influence of Tissue Procurement Procedures on RNA Integrity, Gene Expression, and Morphology in Porcine and Human Liver Tissue. Biopreservation and Biobanking. 13(3). 200–206. 20 indexed citations
7.
Kap, Marcel, et al.. (2014). Fit for Purpose Frozen Tissue Collections by RNA Integrity Number-Based Quality Control Assurance at the Erasmus MC Tissue Bank. Biopreservation and Biobanking. 12(2). 81–90. 41 indexed citations
8.
Riegman, Peter. (2014). From AAA+ to BB− and on the Way Back Again. Biopreservation and Biobanking. 12(5). 292–293. 1 indexed citations
9.
Kap, Marcel, et al.. (2013). Inactivation of Influenza A virus , Adenovirus, and Cytomegalovirus with PAXgene Tissue Fixative and Formalin. Biopreservation and Biobanking. 11(4). 229–234. 9 indexed citations
10.
Chabannon, Christian, Peter Doran, Paul Hofman, et al.. (2012). Annual Conferences of the European, Middle Eastern and African Society for Biopreservation and Biobanking (ESBB): Overview of 2011 and Preview of 2012. Biopreservation and Biobanking. 10(5). 407–415. 1 indexed citations
11.
Riegman, Peter, Maria Grazia Daidone, & Angelo Paradiso. (2011). Concluding Remarks: “Biobanking for Cancer Research: Rules and Roles,” November 2010, Bari, Italy. Biopreservation and Biobanking. 9(2). 195–196. 1 indexed citations
12.
Somiari, Stella, Peter Riegman, Manuel M. Morente, John M. Baust, & Glyn Stacey. (2011). What are Some Top Accomplishments You Would Like to See in the Field by 2015?. Biopreservation and Biobanking. 9(1). 3–4. 2 indexed citations
13.
Vaught, Jim, John G. Baust, Peter Riegman, et al.. (2010). What Are Three Actionable Strategies to Improve Quality in Biomedical Research. Biopreservation and Biobanking. 8(3). 121–125. 4 indexed citations
14.
Hou, Jun, Joachim G.J.V. Aerts, Bianca den Hamer, et al.. (2010). Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction. PLoS ONE. 5(4). e10312–e10312. 614 indexed citations breakdown →
15.
Hainaut, Pierre, Élodie Caboux, Generoso Bevilacqua, et al.. (2009). Pathology as the Cornerstone of Human Tissue Banking: European Consensus Expert Group Report. Biopreservation and Biobanking. 7(3). 157–160. 15 indexed citations
16.
Riegman, Peter, et al.. (2008). Biobanking for better healthcare. Molecular Oncology. 2(3). 213–222. 193 indexed citations
17.
Teodorović, Ivana, et al.. (2006). Virtual Microscopy in Virtual Tumor Banking. Advances in experimental medicine and biology. 587. 75–86. 10 indexed citations
18.
Hulsebos, Theo J.M., et al.. (1996). Identification and characterization of NF1 -related loci on human chromosomes 22, 14 and 2. Human Genetics. 98(1). 7–11. 27 indexed citations
19.
Bakker, Marinka A.H., Peter Riegman, W.J.A. Boersma, et al.. (1995). The NF2 protein co-localizes with elements of the cytoskeleton. American Journal Of Pathology. 5. 1339–1349. 1 indexed citations
20.
Riegman, Peter, R.J. Vlietstra, Paul Klaassen, et al.. (1989). The prostate‐specific antigen gene and the human glandular kallikrein‐1 gene are tandemly located on chromosome 19. FEBS Letters. 247(1). 123–126. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026